Connected scientific context.
Organizing complex information across modalities while preserving source, relationship, and intended use.
MultigemTechnologies
Multigem Technologies · Atlanta, Georgia
We develop software that connects complex data, AI-assisted research, evidence, and governance in one controlled environment.
Evidence, intelligence, and control in context.
The company
Multigem Technologies is building software for research and data-intensive environments where context, control, and traceability matter.
We bring data science, software engineering, analytics, and governance together so teams can work with complex information without separating the analysis from the evidence and rules that give it meaning.
PigmentOS is our flagship platform and first biomedical implementation. It also establishes a reusable product foundation for future scientific and regulated-data applications.
Organizing complex information across modalities while preserving source, relationship, and intended use.
Building AI assistance around evidence, permissions, validation state, and appropriate human oversight.
Turning governance and technical controls into clear workflows for researchers, technical teams, and institutional users.
Platform direction
Our direction is to make advanced analytics and AI more usable in environments where evidence, provenance, data rights, and controlled execution matter.
AI-supported work is designed to operate within defined data, permission, evidence, and use boundaries rather than outside them.
Provenance, validation state, data rights, supporting evidence, and limitations remain visible alongside scientific work.
We are developing product patterns for research organizations, life sciences teams, healthcare research environments, and other controlled scientific workflows.
Our flagship product

PigmentOS brings clinical context, imaging, genomics, single-cell, proteomics, drug-response, and knowledge resources into a unified scientific workspace, with an initial focus on pigment biology, melanocytes, and melanoma.
AI-assisted exploration remains connected to the context that gives evidence meaning, including provenance, validation state, data rights, permissions, and intended use.
Currently in limited preview with synthetic data. Access requires authorization. Research use only; not for diagnosis or treatment.
Clinical context, imaging, genomics, single-cell, proteomics, drug response, and knowledge resources in one environment.
Provenance, data rights, validation state, permissions, and intended use considered alongside the research.
AI-supported exploration designed to remain bounded by the platform’s research and governance context.
How we build
Scientific software should make its evidence, limits, permissions, and intended use easier to understand.
Source, provenance, validation state, meaning, and limitations should travel with the information they describe.
AI capabilities should operate within explicit authorization, data-use, and workflow constraints.
Clear language, accessible interfaces, auditable decisions, and deliberate workflows guide our product decisions.
Meet the founder
Founder & Technical Lead
Atlanta, Georgia
Desriee founded Multigem Technologies to turn complex information into software people can understand and use. She leads the company’s product direction and technical development, including its flagship platform, PigmentOS.
Her background spans enterprise analytics, clinical research technology, data integration, reporting, and data governance. That experience informs a practical approach to building: understand the workflow, respect the evidence, and make the system clear to the person using it.
Start a conversation
For product questions, research collaborations, pilot opportunities, strategic partnerships, investment conversations, or company inquiries, get in touch with Multigem.
This company website introduces Multigem Technologies and its work. It has no account registration, payment collection, contact form, advertising trackers, or analytics scripts.
Email links open your email application. If you contact us, your message and contact information are used to respond to your inquiry and manage the related conversation. Please do not send patient records, confidential research data, or other sensitive material through general email.
The hosting provider may process connection and security information to deliver and protect the website. PigmentOS is a separate application with its own access controls. A link from this website does not grant access to the product.
Multigem Technologies has filed a U.S. provisional patent application related to aspects of PigmentOS. Proprietary implementation details are not disclosed on this website.
If you encounter difficulty using this site or have a question about your information, email info@multigemtechnologies.com.